MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to halt Cancer's deadly spread in first human test
Disease control Recruiting nowThis is the first-ever study in people of an experimental drug called metarrestin. The main goals are to find a safe dose and see if it can shrink tumors. It is for adults and teenagers (12+) with advanced solid tumors that have spread and have not been cured by standard treatmen…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Simple blood test could spot dangerous nerve tumors sooner
Diagnosis Recruiting nowThis study is testing whether a 'liquid biopsy'—a simple blood test—can detect a dangerous type of nerve tumor (MPNST) earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will follow 1,000 adults with NF1 for five years, collecting blood sample…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Sponsor: David Miller • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC